• MindLight, LLC

    30 Lincoln Street Newton Highlands, MA 02461

  • Research Site Introduction:

    The study is being done by a new start-up, MindLight, LLC, which has applied for a SBIR grant through the National Instituted of Drug Abuse. In the mean time we have decided to do a barebones, self-funded, blind placebo-controlled study of unilateral photobiomodulation, near infra-red mode applied to the sides of the forehead. In preliminary studies, Dr. Schiffer, the founder of MindLight, published the first study of photobiomodulation for anxiety and depression, Behavioral and Brain Functions 2009, 5:46, "Psychological benefits 2 and 4 weeks after a single treatment with near infrared light to the forehead: a pilot study of 10 patients with major depression and anxiety." The study was performed at MGH. Since then the positive findings have been replicated in 4 studies. We are testing unilateral treatments (to a healthier hemisphere) as opposed to bilateral treatments. We are now focusing on opioid use disorders. If we are awarded the SBIR grant, we will partner with a laboratory from McLean Hospital as the institutional component, but the current study is solely by MindLight, LLC and this is its first study since its founding in January 2019.

  • Research Site Description:

    MindLight, LLC offices are fully equipted to perform this study. It is located at 30 Lincoln Street, Newton Highlands, MA 02461.

  • Patient Demographics:

    For this study we are looking for people who are current or recent opioid users who are male or female between the ages of 18 and 60. We will exclude pregnant females. Patients can call and have a phone interview to see if they meet our inclusion criterion.

  • Additional Information:

    The study will consist of 3 visits, each paying $30, the first will be an hour to an hour and a half, the second and third will be 30 minutes. The first session will consits of going over the consent form and consenting to the study, having a clinical history and baseline measures of drug cravings, use, and psychological state. The subject will be given a pregnancy test, urine drug screen, Hamilton Depression Rating Scale, Hmilton Anxiety Rating Scale, PANAS scale, and a computer test for hemispheric emotional valence. The treatment will be either a sham or active treament. After the treatment the measures will be repeated. The following week the same measures will be repeated and the treatment will be whichever, active or sham that the subject did not receive the first week. The order of the treatments will be randomized by the blinder. The patient will return the 3rd week for a follow-up of the second treatment and will be given the same psychomentrics. To date many studies have been done with photobiomodulation to the head and no significant side-effects have yet been observed and it is considered a non-significant risk device. The study is IRB approved.

  • Contact Information:

    Fredric Schiffer, MD

    MindLight, LLC

    30 Lincoln Street

    Newton Highlands, MA 02461

    781-405-8800

Active Studies:

There are no active studies for this clinic.